Navigation Links
Alexza Pharmaceuticals Reacquires U.S. and Canadian Rights for AZ-004 (Staccato® Loxapine)
Date:10/19/2010

termination, neither company has any ongoing or future obligations to the other.

About Alexza Pharmaceuticals, Inc.

Alexza Pharmaceuticals is a pharmaceutical company focused on the research, development and commercialization of novel, proprietary products for the acute treatment of central nervous system conditions. Alexza's technology, the Staccato® system, vaporizes unformulated drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience. (Click here to see an animation of how the Staccato system works.)

AZ-004 (Staccato loxapine) is Alexza's lead program, which is being developed for the rapid treatment of agitation in schizophrenic or bipolar disorder patients. Alexza has completed and announced positive results from both of its AZ-004 Phase 3 clinical trials and submitted a New Drug Application (NDA) in December 2009.  In October 2010, Alexza received a Complete Response Letter for the AZ-004 NDA from the U.S. Food and Drug Administration (FDA), which the Company is reviewing, and plans to discuss with the FDA.  For more information about Alexza, the Staccato technology or the Company's development programs, please visit www.alexza.com.

Safe Harbor Statement

This press release includes forward-looking statements regarding the development and safety of the Company's product candidates and technologies.  Any statement describing the Company's expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, an
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 2014  BC Technical, the largest nationwide, non-OEM provider ... Inc., a leading provider of Siemens Nuclear Medicine and ... naming BC Technical as the authorized provider of service ... and BC Technical announced today that the two companies ... as the service and systems provider for MiE,s camera ...
(Date:7/10/2014)... , July 10, 2014 CVS Caremark Corporation ... of directors has approved a quarterly dividend of $0.275 (27.5 ... is payable on August 1, 2014, to holders of record ... CVS Caremark is dedicated to helping people on ... company in the United States . Through ...
(Date:1/15/2014)... DUBLIN , Jan. 15, 2014  Research and Markets ... "Dental Consumables Market - Global Industry Analysis, Size, ... report to their offering. (Logo: ... products which are used on patients in order to ...
Breaking Medicine Technology:BC Technical Partners With MiE America To Be Authorized Provider Of Systems & Service 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3
... MASON, Ohio, May 30, 2012   AssureRx Health, ... $12.5 million Series C financing. The personalized medicine ... select the right drug for individual neuropsychiatric patients, ... for its two flagship pharmacogenomic products, GeneSightRx® Psychotropic ...
... May 30, 2012 The House is scheduled to vote on ... bill is weaker than similar legislation passed by the Senate ... patients from unsafe medical devices, according to Consumers Union, the ... "The FDA is hamstrung by a weak medical device law ...
Cached Medicine Technology:AssureRx Health Raises $12.5 Million Series C Financing 2AssureRx Health Raises $12.5 Million Series C Financing 3AssureRx Health Raises $12.5 Million Series C Financing 4House Voting Today on FDA Reform Act 2
(Date:7/11/2014)... Pigments are insoluble colorants, which usually ... namely protective coating, opacity, and coloring. These are water ... color to substances such as paper, paints, plastics, and ... upon application impart color to the substance. Some examples ... and hematite. , The coloring action of pigments is ...
(Date:7/11/2014)... WASHINGTON Young adults who screened positive for a history ... by more than 50 percent after receiving mobile phone ... according to a study published online yesterday in ... Alcohol Intervention for Young Adult Emergency Department Patients: A ... U.S., more than 50,000 adults ages 18 to 24 ...
(Date:7/11/2014)... UT (PRWEB) July 11, 2014 WWTrek ... at the Kilimanjaro Kids Community in Tanzania. Opened in 2012, ... 150 chickens, and two cows. HOP Founder, Dean Cardinale, started ... for some of the orphaned children he encountered while running ... Team visited the children, who have all made astounding progress ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Fadhits.com, the ... its elegant assortment of lace holiday dresses . ... products are now offered at discounted prices, up to ... website can enjoy this special offer. , Fadhits.com ... and special occasion dresses for the global clients. All ...
(Date:7/11/2014)... that people who have grown up on a farm ... urban counterparts to develop the most common inflammatory bowel ... have recently been published in the European Journal ... we can now see that not only allergic diseases, ... on the environment we are exposed to early in ...
Breaking Medicine News(10 mins):Health News:Americas Pigments Market Worth 1,099 Thousand MT by 2018 - New Report by MicroMarket Monitor 2Health News:Americas Pigments Market Worth 1,099 Thousand MT by 2018 - New Report by MicroMarket Monitor 3Health News:Text message medicine: Texts from the ER can reduce binge drinking 2Health News:Human Outreach Project Sees Incredible Progress in the Kilimanjaro Kids Community 2Health News:Elegant Lace Holiday Dresses Released by Fadhits.com 2Health News:Growing up on a livestock farm halves the risk of inflammatory bowel diseases 2
... 24 Twinlab is proud to announce the success of Team ... Mighty Montauk Triathlon. With winners in most divisions, Full Throttle Twinlab ... of a 1 mile swim, 22 mile bike ride and a ... Kalley placed second and for her first win, Allison Lind took ...
... lives of many humans, it is also a major threat ... study by the Wildlife Conservation Society (WCS). A newly ... Cancer compiles information on cancer in wildlife and suggests ... WCS authors highlight the critical need to protect both animals ...
... in Annals of Internal Medicine , , ... Bulletin Board: NVLX), an emerging healthcare consumer products company, ... in Cinnechol, one of the Company,s primary supplement products, ... lipoprotein, or LDL cholesterol, in dyslipidemic patients. LDL cholesterol ...
... Releases "Go Green" Principles to Change the Nature of ... VHA Inc., the national network of not-for-profit, community-owned ... Citizenship & Sustainability Scorecard , showing progress in ... Ratings also improved in key workplace indicators, including ...
... the American Diabetes Association, nearly 24 million people have ... unaware that they have the disease. Diabetes can affect ... heart and even the mouth. , , ... problems, including tooth decay, periodontal (gum) disease, salivary gland ...
... unconditional love , WEDNESDAY, June 24 (HealthDay News) ... away from less-than-cute babies, according to a study that ... The findings might reflect an evolutionary-based need to provide ... from Harvard-affiliated McLean Hospital in Belmont, Mass. , "Our ...
Cached Medicine News:Health News:Team Full Throttle Twinlab(R) Racing Nabs Podiums in Several Divisions at the 2009 Robert J. Aaron Memorial Mighty Montauk Triathlon 2Health News:Wildlife faces cancer threat 2Health News:Nuvilex Cites Study that Suggests Red Yeast Rice, an Active Ingredient in Cinnechol, Can Help to Improve Cardiovascular Health 2Health News:Nuvilex Cites Study that Suggests Red Yeast Rice, an Active Ingredient in Cinnechol, Can Help to Improve Cardiovascular Health 3Health News:Nuvilex Cites Study that Suggests Red Yeast Rice, an Active Ingredient in Cinnechol, Can Help to Improve Cardiovascular Health 4Health News:VHA Citizenship and Sustainability Scorecard Shows Progress in the Health Care Network's Earth-Friendly Business Practices 2Health News:VHA Citizenship and Sustainability Scorecard Shows Progress in the Health Care Network's Earth-Friendly Business Practices 3Health News:Diabetes: It's Connection to Oral Health 2Health News:Diabetes: It's Connection to Oral Health 3Health News:Women More Likely Than Men to Reject Unattractive Babies 2
Super High Density 360 degree radial rectal transducer. High resolution in the near field and lower frequencies for deeper penetration make this transducer the optimal choice when scanning the anal c...
Multi-frequency, HST, linear transducer with a longer (60mm) footprint. Available with puncture adapter and water path. This transducer incorporates ALOKAs exclusive Hemispheric Sound Technology and ...
... Linear high frequency ... breast and superficial ... exclusive Hemispheric Sound ... technologies. This multi-frequency ...
This versatile convex array abdominal transducer is multi-frequency, offering 5 levels of fundamental frequencies in addition to 4 settings of Harmonic frequencies. This transducer provides superb im...
Medicine Products: